About
Nosis Bio develops receptor-targeted RNA medicines using AI-powered design and delivery technologies to enable gene silencing for the treatment of various chronic diseases.
Explore Nosis Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.